Global Autologous Fat Grafting Device 麻豆原创 Research Report 2025

Publication ID:

PB503254790

Publication Date:

March 4, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global market for Autologous Fat Grafting Device was valued at US$ 400 million in the year 2024 and is projected to reach a revised size of US$ 574 million by 2031, growing at a CAGR of 5.4% during the forecast period.
North American market for Autologous Fat Grafting Device is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Autologous Fat Grafting Device is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Autologous Fat Grafting Device include Solta Medical, Cynosure Inc., Alma Lasers, AbbVie, Cutera, Erchonia, Bimini Health Tech, Candela Medical, Wells Johnson Co., Genesis Biosystems, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Autologous Fat Grafting Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autologous Fat Grafting Device.
The Autologous Fat Grafting Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Autologous Fat Grafting Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Autologous Fat Grafting Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Solta Medical
Cynosure Inc.
Alma Lasers
AbbVie
Cutera
Erchonia
Bimini Health Tech
Candela Medical
Wells Johnson Co.
Genesis Biosystems
Human Med
Moeller Medical
MicroAire Surgical
Smart Lipo
MTF Biologics
Segment by Type
Laser-Based
Ultrasound Assisted
Power Assisted
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Autologous Fat Grafting Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Autologous Fat Grafting Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Autologous Fat Grafting Device 麻豆原创 Overview
1.1 Product Definition
1.2 Autologous Fat Grafting Device by Type
1.2.1 Global Autologous Fat Grafting Device 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 Laser-Based
1.2.3 Ultrasound Assisted
1.2.4 Power Assisted
1.3 Autologous Fat Grafting Device by Application
1.3.1 Global Autologous Fat Grafting Device 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Autologous Fat Grafting Device 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Autologous Fat Grafting Device Revenue 2020-2031
1.4.2 Global Autologous Fat Grafting Device Sales 2020-2031
1.4.3 Global Autologous Fat Grafting Device 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Autologous Fat Grafting Device 麻豆原创 Competition by Manufacturers
2.1 Global Autologous Fat Grafting Device Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Autologous Fat Grafting Device Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Autologous Fat Grafting Device Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Autologous Fat Grafting Device, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Autologous Fat Grafting Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Autologous Fat Grafting Device, Product Type & Application
2.7 Global Key Manufacturers of Autologous Fat Grafting Device, Date of Enter into This Industry
2.8 Global Autologous Fat Grafting Device 麻豆原创 Competitive Situation and Trends
2.8.1 Global Autologous Fat Grafting Device 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Autologous Fat Grafting Device Players 麻豆原创 Share by Revenue
2.8.3 Global Autologous Fat Grafting Device 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Autologous Fat Grafting Device 麻豆原创 Scenario by Region
3.1 Global Autologous Fat Grafting Device 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Autologous Fat Grafting Device Sales by Region: 2020-2031
3.2.1 Global Autologous Fat Grafting Device Sales by Region: 2020-2025
3.2.2 Global Autologous Fat Grafting Device Sales by Region: 2026-2031
3.3 Global Autologous Fat Grafting Device Revenue by Region: 2020-2031
3.3.1 Global Autologous Fat Grafting Device Revenue by Region: 2020-2025
3.3.2 Global Autologous Fat Grafting Device Revenue by Region: 2026-2031
3.4 North America Autologous Fat Grafting Device 麻豆原创 Facts & Figures by Country
3.4.1 North America Autologous Fat Grafting Device 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Autologous Fat Grafting Device Sales by Country (2020-2031)
3.4.3 North America Autologous Fat Grafting Device Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Autologous Fat Grafting Device 麻豆原创 Facts & Figures by Country
3.5.1 Europe Autologous Fat Grafting Device 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Autologous Fat Grafting Device Sales by Country (2020-2031)
3.5.3 Europe Autologous Fat Grafting Device Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Autologous Fat Grafting Device 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Autologous Fat Grafting Device 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Autologous Fat Grafting Device Sales by Region (2020-2031)
3.6.3 Asia Pacific Autologous Fat Grafting Device Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Autologous Fat Grafting Device 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Autologous Fat Grafting Device 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Autologous Fat Grafting Device Sales by Country (2020-2031)
3.7.3 Latin America Autologous Fat Grafting Device Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Autologous Fat Grafting Device 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Autologous Fat Grafting Device 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Autologous Fat Grafting Device Sales by Country (2020-2031)
3.8.3 Middle East and Africa Autologous Fat Grafting Device Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Autologous Fat Grafting Device Sales by Type (2020-2031)
4.1.1 Global Autologous Fat Grafting Device Sales by Type (2020-2025)
4.1.2 Global Autologous Fat Grafting Device Sales by Type (2026-2031)
4.1.3 Global Autologous Fat Grafting Device Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Autologous Fat Grafting Device Revenue by Type (2020-2031)
4.2.1 Global Autologous Fat Grafting Device Revenue by Type (2020-2025)
4.2.2 Global Autologous Fat Grafting Device Revenue by Type (2026-2031)
4.2.3 Global Autologous Fat Grafting Device Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Autologous Fat Grafting Device Price by Type (2020-2031)
5 Segment by Application
5.1 Global Autologous Fat Grafting Device Sales by Application (2020-2031)
5.1.1 Global Autologous Fat Grafting Device Sales by Application (2020-2025)
5.1.2 Global Autologous Fat Grafting Device Sales by Application (2026-2031)
5.1.3 Global Autologous Fat Grafting Device Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Autologous Fat Grafting Device Revenue by Application (2020-2031)
5.2.1 Global Autologous Fat Grafting Device Revenue by Application (2020-2025)
5.2.2 Global Autologous Fat Grafting Device Revenue by Application (2026-2031)
5.2.3 Global Autologous Fat Grafting Device Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Autologous Fat Grafting Device Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Solta Medical
6.1.1 Solta Medical Company Information
6.1.2 Solta Medical Description and Business Overview
6.1.3 Solta Medical Autologous Fat Grafting Device Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Solta Medical Autologous Fat Grafting Device Product Portfolio
6.1.5 Solta Medical Recent Developments/Updates
6.2 Cynosure Inc.
6.2.1 Cynosure Inc. Company Information
6.2.2 Cynosure Inc. Description and Business Overview
6.2.3 Cynosure Inc. Autologous Fat Grafting Device Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Cynosure Inc. Autologous Fat Grafting Device Product Portfolio
6.2.5 Cynosure Inc. Recent Developments/Updates
6.3 Alma Lasers
6.3.1 Alma Lasers Company Information
6.3.2 Alma Lasers Description and Business Overview
6.3.3 Alma Lasers Autologous Fat Grafting Device Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Alma Lasers Autologous Fat Grafting Device Product Portfolio
6.3.5 Alma Lasers Recent Developments/Updates
6.4 AbbVie
6.4.1 AbbVie Company Information
6.4.2 AbbVie Description and Business Overview
6.4.3 AbbVie Autologous Fat Grafting Device Sales, Revenue and Gross Margin (2020-2025)
6.4.4 AbbVie Autologous Fat Grafting Device Product Portfolio
6.4.5 AbbVie Recent Developments/Updates
6.5 Cutera
6.5.1 Cutera Company Information
6.5.2 Cutera Description and Business Overview
6.5.3 Cutera Autologous Fat Grafting Device Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Cutera Autologous Fat Grafting Device Product Portfolio
6.5.5 Cutera Recent Developments/Updates
6.6 Erchonia
6.6.1 Erchonia Company Information
6.6.2 Erchonia Description and Business Overview
6.6.3 Erchonia Autologous Fat Grafting Device Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Erchonia Autologous Fat Grafting Device Product Portfolio
6.6.5 Erchonia Recent Developments/Updates
6.7 Bimini Health Tech
6.7.1 Bimini Health Tech Company Information
6.7.2 Bimini Health Tech Description and Business Overview
6.7.3 Bimini Health Tech Autologous Fat Grafting Device Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bimini Health Tech Autologous Fat Grafting Device Product Portfolio
6.7.5 Bimini Health Tech Recent Developments/Updates
6.8 Candela Medical
6.8.1 Candela Medical Company Information
6.8.2 Candela Medical Description and Business Overview
6.8.3 Candela Medical Autologous Fat Grafting Device Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Candela Medical Autologous Fat Grafting Device Product Portfolio
6.8.5 Candela Medical Recent Developments/Updates
6.9 Wells Johnson Co.
6.9.1 Wells Johnson Co. Company Information
6.9.2 Wells Johnson Co. Description and Business Overview
6.9.3 Wells Johnson Co. Autologous Fat Grafting Device Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Wells Johnson Co. Autologous Fat Grafting Device Product Portfolio
6.9.5 Wells Johnson Co. Recent Developments/Updates
6.10 Genesis Biosystems
6.10.1 Genesis Biosystems Company Information
6.10.2 Genesis Biosystems Description and Business Overview
6.10.3 Genesis Biosystems Autologous Fat Grafting Device Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Genesis Biosystems Autologous Fat Grafting Device Product Portfolio
6.10.5 Genesis Biosystems Recent Developments/Updates
6.11 Human Med
6.11.1 Human Med Company Information
6.11.2 Human Med Description and Business Overview
6.11.3 Human Med Autologous Fat Grafting Device Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Human Med Autologous Fat Grafting Device Product Portfolio
6.11.5 Human Med Recent Developments/Updates
6.12 Moeller Medical
6.12.1 Moeller Medical Company Information
6.12.2 Moeller Medical Description and Business Overview
6.12.3 Moeller Medical Autologous Fat Grafting Device Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Moeller Medical Autologous Fat Grafting Device Product Portfolio
6.12.5 Moeller Medical Recent Developments/Updates
6.13 MicroAire Surgical
6.13.1 MicroAire Surgical Company Information
6.13.2 MicroAire Surgical Description and Business Overview
6.13.3 MicroAire Surgical Autologous Fat Grafting Device Sales, Revenue and Gross Margin (2020-2025)
6.13.4 MicroAire Surgical Autologous Fat Grafting Device Product Portfolio
6.13.5 MicroAire Surgical Recent Developments/Updates
6.14 Smart Lipo
6.14.1 Smart Lipo Company Information
6.14.2 Smart Lipo Description and Business Overview
6.14.3 Smart Lipo Autologous Fat Grafting Device Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Smart Lipo Autologous Fat Grafting Device Product Portfolio
6.14.5 Smart Lipo Recent Developments/Updates
6.15 MTF Biologics
6.15.1 MTF Biologics Company Information
6.15.2 MTF Biologics Description and Business Overview
6.15.3 MTF Biologics Autologous Fat Grafting Device Sales, Revenue and Gross Margin (2020-2025)
6.15.4 MTF Biologics Autologous Fat Grafting Device Product Portfolio
6.15.5 MTF Biologics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Autologous Fat Grafting Device Industry Chain Analysis
7.2 Autologous Fat Grafting Device Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Autologous Fat Grafting Device Production Mode & Process Analysis
7.4 Autologous Fat Grafting Device Sales and 麻豆原创ing
7.4.1 Autologous Fat Grafting Device Sales Channels
7.4.2 Autologous Fat Grafting Device Distributors
7.5 Autologous Fat Grafting Device Customer Analysis
8 Autologous Fat Grafting Device 麻豆原创 Dynamics
8.1 Autologous Fat Grafting Device Industry Trends
8.2 Autologous Fat Grafting Device 麻豆原创 Drivers
8.3 Autologous Fat Grafting Device 麻豆原创 Challenges
8.4 Autologous Fat Grafting Device 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Solta Medical
Cynosure Inc.
Alma Lasers
AbbVie
Cutera
Erchonia
Bimini Health Tech
Candela Medical
Wells Johnson Co.
Genesis Biosystems
Human Med
Moeller Medical
MicroAire Surgical
Smart Lipo
MTF Biologics

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.